Frindel E - Search Results

1

Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay.

Pradelles P, Frobert Y, Créminon C, Liozon E, Massé A, Frindel E. Pradelles P, et al. Among authors: frindel e. Biochem Biophys Res Commun. 1990 Aug 16;170(3):986-93. doi: 10.1016/0006-291x(90)90489-a. Biochem Biophys Res Commun. 1990. PMID: 2202303

2

Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues.

Pradelles P, Frobert Y, Créminon C, Ivonine H, Frindel E. Pradelles P, et al. Among authors: frindel e. FEBS Lett. 1991 Sep 9;289(2):171-5. doi: 10.1016/0014-5793(91)81062-d. FEBS Lett. 1991. PMID: 1915845 Free article.

3

Serum levels of a negative regulator of cell proliferation (AcSDKP) are increased in certain human haemopathies.

Liozon E, Pradelles P, Venot J, Rigaud M, Cransac M, Bordessoule D, Frindel E. Liozon E, et al. Among authors: frindel e. Leukemia. 1993 Jun;7(6):808-12. Leukemia. 1993. PMID: 8501976

4

Correlation of endogenous acetyl-ser-asp-lys-pro plasma levels in mice and the kinetics of pluripotent hemopoietic stem cells entry into the cycle after cytosine arabinoside treatment: fundamental and clinical aspects.

Frindel E, Masse A, Pradelles P, Volkov L, Rigaud M. Frindel E, et al. Leukemia. 1992 Jun;6(6):599-601. Leukemia. 1992. PMID: 1602798

5

Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.

Lopez M, Wdzieczak-Bakala J, Pradelles P, Frindel E. Lopez M, et al. Among authors: frindel e. Leukemia. 1991 Mar;5(3):270-2. Leukemia. 1991. PMID: 2013983

6

[Study of the role of negative regulator, AcSer-Asp-Lys-Pro (AcSDKP) in the phenomena of cellular proliferation].

Volkov L, Pradelles P, Comte L, Frindel E. Volkov L, et al. Among authors: frindel e. C R Acad Sci III. 1992;315(12):499-504. C R Acad Sci III. 1992. PMID: 1297528 French.

7

Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part I. MLR with mouse spleen cells.

Frindel E, Massé A, Volkov L, Lavignac C, Rigaud M. Frindel E, et al. Leukemia. 1992 Oct;6(10):1043-4. Leukemia. 1992. PMID: 1405757

8

Inhibitory effects of AcSDKP on the mixed lymphocyte reaction (MLR). Part II. Human whole blood cells.

Lavignac C, Volkov L, Massé A, Rigaud M, Frindel E. Lavignac C, et al. Among authors: frindel e. Leukemia. 1992 Oct;6(10):1045-7. Leukemia. 1992. PMID: 1405758

9

A low-molecular-weight factor extracted from human placenta inhibits the entry into cell cycle of murine pluripotent stem cells.

Lopez M, Wdzieczak-Bakala J, Pradelles P, Bony V, Frindel E. Lopez M, et al. Among authors: frindel e. Ann N Y Acad Sci. 1991;628:169-71. doi: 10.1111/j.1749-6632.1991.tb17237.x. Ann N Y Acad Sci. 1991. PMID: 2069297 No abstract available.

10

AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia.

Liozon E, Volkov L, Comte L, Trimoreau F, Pradelles P, Bordessoule D, Frindel E, Praloran V. Liozon E, et al. Among authors: frindel e. Br J Haematol. 1995 Apr;89(4):917-20. doi: 10.1111/j.1365-2141.1995.tb08438.x. Br J Haematol. 1995. PMID: 7772535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters